Tobias B. Huber

39.1k total citations · 4 hit papers
257 papers, 12.7k citations indexed

About

Tobias B. Huber is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Tobias B. Huber has authored 257 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Nephrology, 100 papers in Molecular Biology and 43 papers in Genetics. Recurrent topics in Tobias B. Huber's work include Renal Diseases and Glomerulopathies (122 papers), Renal and related cancers (40 papers) and Chronic Kidney Disease and Diabetes (38 papers). Tobias B. Huber is often cited by papers focused on Renal Diseases and Glomerulopathies (122 papers), Renal and related cancers (40 papers) and Chronic Kidney Disease and Diabetes (38 papers). Tobias B. Huber collaborates with scholars based in Germany, United States and United Kingdom. Tobias B. Huber's co-authors include Gerd Walz, Thomas Benzing, Florian Grahammer, Björn Hartleben, Christoph Schell, Oliver Kretz, Mario Schiffer, Berend Isermann, Hans‐Joachim Anders and Shuya Liu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Tobias B. Huber

234 papers receiving 12.6k citations

Hit Papers

Mitochondrial Dynamics Controls T Cell Fate through Me... 2010 2026 2015 2020 2016 2010 2018 2011 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tobias B. Huber Germany 56 5.7k 5.2k 1.8k 1.7k 1.7k 257 12.7k
Katalin Suszták United States 61 8.2k 1.4× 6.1k 1.2× 1.9k 1.0× 1.6k 1.0× 1.6k 0.9× 190 16.1k
Yashpal S. Kanwar United States 59 6.3k 1.1× 3.7k 0.7× 1.4k 0.8× 1.6k 0.9× 1.1k 0.7× 234 13.8k
Jochen Reiser United States 51 5.3k 0.9× 9.1k 1.7× 2.0k 1.1× 1.7k 1.0× 639 0.4× 179 14.1k
Stuart J. Shankland United States 70 6.8k 1.2× 8.4k 1.6× 2.3k 1.3× 1.8k 1.1× 478 0.3× 229 15.2k
Susan E. Quaggin United States 60 6.0k 1.0× 4.4k 0.8× 1.5k 0.9× 1.3k 0.8× 478 0.3× 156 12.2k
Benjamin D. Humphreys United States 71 8.6k 1.5× 4.9k 0.9× 1.3k 0.7× 2.0k 1.1× 835 0.5× 184 16.9k
Volker H. Haase United States 60 6.4k 1.1× 1.6k 0.3× 2.0k 1.1× 2.1k 1.2× 937 0.6× 114 14.9k
Hermann-Josef Gröne Germany 62 5.0k 0.9× 1.7k 0.3× 878 0.5× 2.7k 1.6× 776 0.5× 170 11.9k
George F. Schreiner United States 56 4.2k 0.7× 3.1k 0.6× 792 0.4× 1.5k 0.9× 975 0.6× 139 11.3k
Emile de Heer Netherlands 47 2.9k 0.5× 2.6k 0.5× 1.7k 0.9× 1.3k 0.8× 478 0.3× 204 8.5k

Countries citing papers authored by Tobias B. Huber

Since Specialization
Citations

This map shows the geographic impact of Tobias B. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias B. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias B. Huber more than expected).

Fields of papers citing papers by Tobias B. Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias B. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias B. Huber. The network helps show where Tobias B. Huber may publish in the future.

Co-authorship network of co-authors of Tobias B. Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias B. Huber. A scholar is included among the top collaborators of Tobias B. Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias B. Huber. Tobias B. Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lagies, Simon, D.‐Ch. Neugebauer, Tobias B. Huber, et al.. (2025). Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA. International Journal of Molecular Sciences. 26(5). 2272–2272.
2.
Hengel, Felicitas E., et al.. (2025). Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions. Journal of Clinical Investigation. 135(5). 7 indexed citations
3.
Rissiek, Björn, Christian F. Krebs, Hans‐Willi Mittrücker, et al.. (2024). ATP-Gated P2X7-Ion Channel on Kidney-Resident Natural Killer T Cells and Memory T Cells in Intrarenal Inflammation. Journal of the American Society of Nephrology. 36(4). 602–613. 3 indexed citations
4.
Rupprecht, Harald, Kerstin Amann, Felicitas E. Hengel, et al.. (2024). Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers. International Journal of Molecular Sciences. 25(7). 3678–3678. 9 indexed citations
5.
Barreiro, Karina, Abigail C. Lay, Germán Leparc, et al.. (2023). An in vitro approach to understand contribution of kidney cells to human urinary extracellular vesicles. Journal of Extracellular Vesicles. 12(2). e12304–e12304. 22 indexed citations
6.
Zhao, Yu, Hans‐Joachim Paust, Claudia Wegscheid, et al.. (2023). Transcriptional and Clonal Characterization of Cytotoxic T Cells in Crescentic Glomerulonephritis. Journal of the American Society of Nephrology. 34(6). 1003–1018. 10 indexed citations
7.
Lindenmeyer, Maja T., Catherine Meyer‐Schwesinger, Heimo Ehmke, et al.. (2023). Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II–Induced Hypertension and Hypertensive End-Organ Damage. Hypertension. 81(1). 138–150. 4 indexed citations
8.
Drexler, Richard, Thomas Sauvigny, Ulrich Schüller, et al.. (2023). Epigenetic profiling reveals a strong association between lack of 5-ALA fluorescence and EGFR amplification in IDH-wildtype glioblastoma. Neuro-Oncology Practice. 10(5). 462–471. 1 indexed citations
9.
Rauch, Simon, Raimund Lechner, Giacomo Strapazzon, et al.. (2023). Suspension syndrome: a scoping review and recommendations from the International Commission for Mountain Emergency Medicine (ICAR MEDCOM). Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 31(1). 95–95. 1 indexed citations
10.
Shedden‐Mora, Meike, Christian Schmidt‐Lauber, Bernd Löwe, et al.. (2022). Predictors of somatic symptom persistence in patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methods cohort study. BMJ Open. 12(11). e067821–e067821. 1 indexed citations
11.
Löwe, Bernd, Viola Andresen, Omer Van den Bergh, et al.. (2022). Persistent SOMAtic symptoms ACROSS diseases — from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211). BMJ Open. 12(1). e057596–e057596. 61 indexed citations
12.
Mitchell, Robert D., Oliver Kretz, David Chambers, et al.. (2021). A muscle growth-promoting treatment based on the attenuation of activin/myostatin signalling results in long-term testicular abnormalities. Disease Models & Mechanisms. 14(2). 1 indexed citations
13.
Kluger, Malte A., Jan Czogalla, Christian Schmidt‐Lauber, et al.. (2021). Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19. Transplant Infectious Disease. 23(4). e13685–e13685. 6 indexed citations
14.
Mitchell, Robert D., Manuela Antonioli, Oliver Kretz, et al.. (2017). Protein and Molecular Characterization of a Clinically Compliant Amniotic Fluid Stem Cell-Derived Extracellular Vesicle Fraction Capable of Accelerating Muscle Regeneration Through Enhancement of Angiogenesis. Stem Cells and Development. 26(18). 1316–1333. 42 indexed citations
15.
Grahammer, Florian, Malte Roerden, Nicola Wanner, et al.. (2014). mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proceedings of the National Academy of Sciences. 111(27). E2817–26. 83 indexed citations
16.
Wanner, Nicola, Björn Hartleben, Nadja Herbach, et al.. (2014). Unraveling the Role of Podocyte Turnover in Glomerular Aging and Injury. Journal of the American Society of Nephrology. 25(4). 707–716. 143 indexed citations
17.
Helmstädter, Martin, Kevin Lüthy, Markus Gödel, et al.. (2012). Functional Study of Mammalian Neph Proteins in Drosophila melanogaster. PLoS ONE. 7(7). e40300–e40300. 25 indexed citations
18.
Hartleben, Björn, Markus Gödel, Catherine Meyer‐Schwesinger, et al.. (2010). Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. Journal of Clinical Investigation. 120(4). 1084–1096. 586 indexed citations breakdown →
19.
Skouloudaki, Kassiani, Matias Simons, Christopher Boehlke, et al.. (2009). Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proceedings of the National Academy of Sciences. 106(21). 8579–8584. 116 indexed citations
20.
Huber, Tobias B., Bernhard Schermer, Roman Ulrich Müller, et al.. (2006). Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proceedings of the National Academy of Sciences. 103(46). 17079–17086. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026